Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
We have treated countless patients over the past five years - with the majority of them reaching their goal weight and keeping the weight off
You may also like Product Description PT-141 Peptide | Buy PT-141 UK | Research Use Only PT-141 also known as Bremelanotide and Vyleesi (FDA-approved pharmaceutical formulation) is a synthetic cyclic heptapeptide (Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, MW 1,025.2 Da) originally derived as an active metabolite of Melanotan II and engineered as a non-selective melanocortin receptor agonist with highest affinity for MC4R, acting centrally in the medial preoptic area and paraventricular nucleus of the hypothalamus to modulate dopaminergic, noradrenergic, and serotoninergic neurotransmission governing sexual desire and arousal making it the only CNS-acting melanocortin system research tool with a full Phase II and Phase III clinical evidence base, FDA approval (2019) as Vyleesi for hypoactive sexual desire disorder in premenopausal women, and a pharmacological profile mechanistically distinct from PDE5 inhibitors operating upstream on the neural circuitry of desire rather than downstream on vascular nitric oxide pathways
The manufacture of health products to cover almost every age bracket and population provides various health alternatives to people of diverse age groups and functionalities
By improving blood sugar control and aiding in weight loss, semaglutide can help reduce the accumulation of fat in the liver
An intensive review on their potential as a sustainable and versatile food source for future generations
1 mL (100-unit) syringe Required for large volumes, such as lower concentration vials at higher doses
US$ 28.44
US$ 27.77
US$ 21.25
US$ 20.31
US$ 20.97
US$ 28.11
